BST-1 as a serum protein biomarker involved in neutrophil infiltration in schizophrenia

References

• Al Awam K, Haußleiter IS, Dudley E, Donev R, Brüne M, Juckel G, Thome J. 2015. Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia. J Neural Transm. 122(Suppl 1):S111–S22.
   PubMedGoogle Scholar
• American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental disorders. DSM-IV-TR (Text Revision). Washington, DC: American Psychiatric Association.
   Google Scholar
• Anveden A, Sjoholm K, Jacobson P, Palsdottir V, Walley AJ, Froguel P, Al-Daghri N, McTernan PG, Mejhert N, Arner P, Sjostrom L, et al. 2012. ITIH-5 expression in human adipose tissue is increased in obesity. Obesity. 20(4):708–714.
   PubMed Web of Science ®Google Scholar
• Barnes TR. 2003. The Barnes Akathisia rating scale-revisited. J Psychopharmacol. 17(4):365–370.
   PubMed Web of Science ®Google Scholar
• Cannon TD. 2015. How schizophrenia develops: cognitive and brain mechanisms underlying onset of psychosis. Trends Cogn Sci. 19(12):744–756.
   PubMed Web of Science ®Google Scholar
• Chosa N, Ishisaki A. 2018. Two novel mechanisms for maintenance of stemness in mesenchymal stem cells: SCRG1/BST1 axis and cell-cell adhesion through N-cadherin. Jpn Dent Sci Rev. 54(1):37–44.
   PubMed Web of Science ®Google Scholar
• Chou FH, Chou P, Su TT, Ou-Yang WC, Chien IC, Lu MK, Huang MW. 2004. Quality of life and related risk factors in a Taiwanese Village population 21 months after an earthquake. Aust N Z J Psychiatry. 38(5):358–364.
   PubMed Web of Science ®Google Scholar
• Chou FH, Tsai KY, Wu HC, Shen SP. 2016. Cancer in patients with schizophrenia: What is the next step? Psychiatry Clin Neurosci. 70(11):473–488.
   PubMed Web of Science ®Google Scholar
• Craft GE, Chen A, Nairn AC. 2013. Recent advances in quantitative neuroproteomics. Methods. 61(3):186–218.
   PubMed Web of Science ®Google Scholar
• Dotsch MM, Kloten V, Schlensog M, Heide T, Braunschweig T, Veeck J, Petersen I, Knuchel R, Dahl E. 2015. Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients’ outcome. Epigenetics. 10(10):903–912.
   PubMed Web of Science ®Google Scholar
• Funaro A, Ortolan E, Ferranti B, Gargiulo L, Notaro R, Luzzatto L, Malavasi F. 2004. CD157 is an important mediator of neutrophil adhesion and migration. Blood. 104(13):4269–4278.
   PubMed Web of Science ®Google Scholar
• Guest PC, Guest FL, Martins d, Souza D. 2016. Making sense of blood-based proteomics and metabolomics in psychiatric research. Int J Neuropsychopharmacol. 19(6):pyv138.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Pokhriyal R, Khan MI, Kumar DR, Gupta R, Chadda RK, Ramachandran R, Goyal V, Tripathi M, Hariprasad G. 2019. Cerebrospinal fluid proteomics for identification of α2-macroglobulin as a potential biomarker to monitor pharmacological therapeutic efficacy in dopamine dictated disease states of Parkinson’s Disease and schizophrenia. Neuropsychiatr Dis Treat. 15:2853–2867.
   PubMed Web of Science ®Google Scholar
• Himmelfarb M, Klopocki E, Grube S, Staub E, Klaman I, Hinzmann B, Kristiansen G, Rosenthal A, Durst M, Dahl E. 2004. ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer. Cancer Lett. 204(1):69–77.
   PubMed Web of Science ®Google Scholar
• Huang LH, Kuo HC, Pan CT, Lin YS, Huang YH, Li SC. 2018. Multiomics analyses identified epigenetic modulation of the S100A gene family in Kawasaki disease and their significant involvement in neutrophil transendothelial migration. Clin Epigenetics. 10(1):135.
   PubMedGoogle Scholar
• Kahn RS, Sommer IE, Murray RM, Meyer-Lindenberg A, Weinberger DR, Cannon TD, O’Donovan M, Correll CU, Kane JM, van Os J, et al. 2015. Schizophrenia. Nat Rev Dis Primers. 1:15067.
   PubMed Web of Science ®Google Scholar
• Kaisho T, Ishikawa J, Oritani K, Inazawa J, Tomizawa H, Muraoka O, Ochi T, Hirano T. 1994. BST-1, a surface molecule of bone marrow stromal cell lines that facilitates pre-B-cell growth. Proc Natl Acad Sci U S A. 91(12):5325–5329.
   PubMed Web of Science ®Google Scholar
• Karageorgiou V, Milas GP, Michopoulos I. 2019. Neutrophil-to-lymphocyte ratio in schizophrenia: a systematic review and meta-analysis. Schizophr Res. 206:4–12.
   PubMed Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 13(2):261–276.
   PubMed Web of Science ®Google Scholar
• Kay SR, Opler LA, Lindenmayer JP. 1988. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res. 23(1):99–110.
   PubMed Web of Science ®Google Scholar
• Koga M, Serritella AV, Sawa A, Sedlak TW. 2016. Implications for reactive oxygen species in schizophrenia pathogenesis. Schizophr Res. 176(1):52–71.
   PubMed Web of Science ®Google Scholar
• Kuo CJ, Tang HS, Tsay CJ, Lin SK, Hu WH, Chen CC. 2003. Prevalence of psychiatric disorders among bereaved survivors of a disastrous earthquake in taiwan. Psychiatr Serv. 54(2):249–251.
   PubMed Web of Science ®Google Scholar
• Lane RD, Glazer WM, Hansen TE, Berman WH, Kramer SI. 1985. Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale. J Nerv Ment Dis. 173(6):353–357.
   PubMed Web of Science ®Google Scholar
• Levin Y, Wang L, Schwarz E, Koethe D, Leweke FM, Bahn S. 2010. Global proteomic profiling reveals altered proteomic signature in schizophrenia serum. Mol Psychiatry. 15(11):1088–1100.
   PubMed Web of Science ®Google Scholar
• Liu W, Zou Z, Huang X, Shen H, He LJ, Chen SM, Li LP, Yan L, Zhang SQ, Zhang JD, et al. 2016. Bst1 is required for Candida albicans infecting host via facilitating cell wall anchorage of Glycosylphosphatidyl inositol anchored proteins. Sci Rep. 6:34854.
   PubMed Web of Science ®Google Scholar
• Malavasi F, Deaglio S, Ferrero E, Funaro A, Sancho J, Ausiello CM, Ortolan E, Vaisitti T, Zubiaur M, Fedele G, Aydin S, et al. 2006. CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity. Mol Med. 12(11–12):334–341.
   PubMed Web of Science ®Google Scholar
• Martins-de-Souza D, Guest PC, Rahmoune H, Bahn S. 2012. Proteomic approaches to unravel the complexity of schizophrenia. Expert Rev Proteomics. 9(1):97–108.
   PubMed Web of Science ®Google Scholar
• Moyer CE, Shelton MA, Sweet RA. 2015. Dendritic spine alterations in schizophrenia. Neurosci Lett. 601:46–53.
   PubMed Web of Science ®Google Scholar
• Muller N, Weidinger E, Leitner B, Schwarz MJ. 2015. The role of inflammation in schizophrenia. Front Neurosci. 9:372.
   PubMed Web of Science ®Google Scholar
• Nascimento JM, Martins-de-Souza D. 2015. The proteome of schizophrenia. NPJ Schizophr. 1:14003.
   PubMedGoogle Scholar
• Ortolan E, Tibaldi EV, Ferranti B, Lavagno L, Garbarino G, Notaro R, Luzzatto L, Malavasi F, Funaro A. 2006. CD157 plays a pivotal role in neutrophil transendothelial migration. Blood. 108(13):4214–4222.
   PubMed Web of Science ®Google Scholar
• Ozturk S, Papageorgis P, Wong CK, Lambert AW, Abdolmaleky HM, Thiagalingam A, Cohen HT, Thiagalingam S. 2016. SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis. Proc Natl Acad Sci USA. 113(3):638–643.
   PubMed Web of Science ®Google Scholar
• Packard AEB, Zhang J, Myers B, Ko CW, Wang F, Tso P, Ulrich-Lai YM. 2017. Apolipoprotein A-IV constrains HPA and behavioral stress responsivity in a strain-dependent manner. Psychoneuroendocrinology. 86:34–44.
   PubMed Web of Science ®Google Scholar
• Patel S. 2014. Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders. Adv Protein Chem Struct Biol. 94:39–75.
   PubMed Web of Science ®Google Scholar
• Pérez-Ramírez M, Hernández-Jiménez AJ, Guerrero-Guerrero A, Benadón-Darszon E, Pérezpeña-Díazconti M, Siordia-Reyes AG, García-Méndez A, de León FC-P, Salamanca-Gómez FA, García-Hernández N. 2016. Genomics and epigenetics: a study of ependymomas in pediatric patients. Clin Neurol Neurosurg. 144:53–58.
   PubMed Web of Science ®Google Scholar
• Rimessi A, Pavan C, Ioannidi E, Nigro F, Morganti C, Brugnoli A, Longo F, Gardin C, Ferroni L, Morari M, et al. 2017. Protein Kinase C β: a new target therapy to prevent the long-term atypical antipsychotic-induced weight gain. Neuropsychopharmacology. 42(7):1491–1501.
   PubMed Web of Science ®Google Scholar
• Sabherwal S, English JA, Focking M, Cagney G, Cotter DR. 2016. Blood biomarker discovery in drug-free schizophrenia: the contribution of proteomics and multiplex immunoassays. Expert Rev Proteomics. 13(12):1141–1155.
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 59(Suppl 20):22–33. quiz 4-57.
   PubMed Web of Science ®Google Scholar
• Simpson GM, Angus JW. 1970. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl. 212:11–19.
   PubMedGoogle Scholar
• Steiner J, Guest PC, Martins-de-Souza D. 2017. Application of proteomic techniques for improved stratification and treatment of schizophrenia patients. Adv Exp Med Biol. 974:3–19.
   PubMed Web of Science ®Google Scholar
• Tenca C, Merlo A, Merck E, Bates EE, Saverino D, Simone R, Zarcone D, Trinchieri G, Grossi CE, Ciccone E. 2005. CD85j (leukocyte Ig-like receptor-1/Ig-like transcript 2) inhibits human osteoclast-associated receptor-mediated activation of human dendritic cells. J Immunol. 174(11):6757–6763.
   PubMed Web of Science ®Google Scholar
• Unwin RD. 2010. Quantification of proteins by iTRAQ. Methods Mol Biol. 658:205–215.
   PubMedGoogle Scholar
• Velasquez E, Martins-de-Souza D, Velasquez I, Carneiro GRA, Schmitt A, Falkai P, Domont GB, Nogueira FCS. 2019. Quantitative subcellular proteomics of the orbitofrontal cortex of schizophrenia patients. J Proteome Res. 18(12):4240–4253.
   PubMed Web of Science ®Google Scholar
• Velasquez E, Nogueira FCS, Velasquez I, Schmitt A, Falkai P, Domont GB, Martins-de-Souza D. 2017. Synaptosomal proteome of the orbitofrontal cortex from schizophrenia patients using quantitative label-free and iTRAQ-based shotgun proteomics. J Proteome Res. 16(12):4481–4494.
   PubMed Web of Science ®Google Scholar
• Wang S, Xu YF, Ding XY, Liu ZR, Ding Y, Jin B, Wang S, Ding MP. 2015. Association between bone marrow stromal cell antigen 1 gene polymorphisms and the susceptibility to Parkinson’s disease: a meta-analysis. Neurosci Lett. 599:120–124.
   PubMed Web of Science ®Google Scholar
• Wang Y, Song Z, Leng P, Liu Y. 2019. A systematic analysis reveals gene expression alteration of serum deprivation response (SDPR) gene is significantly associated with the survival of patients with cancer. Oncol Rep. 42(3):1161–1172.
   PubMed Web of Science ®Google Scholar
• WHO. 2021; [accessed 2021 Dec 12]. http://www.whocc.no/atc_ddd_index/.
   Google Scholar
• Wu BJ, Lin CH, Tseng HF, Liu WM, Chen WC, Huang LS, Sun HJ, Chiang SK, Lee SM. 2013. Validation of the Taiwanese mandarin version of the personal and social performance scale in a sample of 655 stable schizophrenic patients. Schizophr Res. 146(1–3):34–39.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Owada Y. 2021. Possible involvement of fatty acid binding proteins in psychiatric disorders. Anat Sci Int. 96(3):333–342.
   PubMed Web of Science ®Google Scholar
• Yang N, Yu L, Deng Y, Han Q, Wang J, Yu L, Zhai Z, Li W. 2020. Identification and characterization of proteins that are differentially expressed in adipose tissue of olanzapine-induced insulin resistance rat by iTRAQ quantitative proteomics. J Proteomics. 212:103570.
   PubMed Web of Science ®Google Scholar
• Yokoyama S, Al Mahmuda N, Munesue T, Hayashi K, Yagi K, Yamagishi M, Higashida H. 2015. Association study between the CD157/BST1 gene and autism spectrum disorders in a Japanese population. Brain Sci. 5(2):188–200.
   PubMedGoogle Scholar
• Zhuo L, Hascall VC, Kimata K. 2004. Inter-alpha-trypsin inhibitor, a covalent protein-glycosaminoglycan-protein complex. J Biol Chem. 279(37):38079–38082.
   PubMed Web of Science ®Google Scholar